AMGN Return on Tangible Equity | Amgen Inc.

Amgen Inc. (AMGN) Return on Tangible Equity

2026-06-30: Return Tang Equity -32.68%.
2026-03-31: Return Tang Equity -25.87%.
2025-12-31: Return Tang Equity -24.41%.
2025-09-30: Return Tang Equity -22.25%.

Complete source-backed return tang equity history.

Available history: 2007-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-32.68%
2026-03-31	-25.87%
2025-12-31	-24.41%
2025-09-30	-22.25%
2025-06-30	-18.83%
2025-03-31	-15.99%
2024-12-31	-10.38%
2024-09-30	-10.86%
2024-06-30	-7.50%
2024-03-31	-8.60%
2023-12-31	-15.33%
2023-09-30	-36.30%
2023-06-30	-35.55%
2023-03-31	-32.23%
2022-12-31	-24.32%
2022-09-30	-29.15%
2022-06-30	-25.94%
2022-03-31	-20.79%
2021-12-31	-26.42%
2021-09-30	-26.61%
2021-06-30	-26.47%
2021-03-31	-33.33%
2020-12-31	-33.26%
2020-09-30	-35.11%
2020-06-30	-33.27%
2020-03-31	-32.22%
2019-12-31	-32.15%
2019-09-30	-77.54%
2019-06-30	-74.70%
2019-03-31	-73.89%
2018-12-31	-87.56%
2018-09-30	-27.32%
2018-06-30	-30.03%
2018-03-31	-29.42%
2017-12-31	87.68%
2017-09-30	91.52%
2017-06-30	100.23%
2017-03-31	117.51%
2016-12-31	138.04%
2016-09-30	120.79%
2016-06-30	140.75%
2016-03-31	209.40%
2015-12-31	256.43%
2015-09-30	168.36%
2015-06-30	199.52%
2015-03-31	343.86%
2014-12-31	1141.15%
2014-09-30	18788.46%
2014-06-30	-382.95%
2014-03-31	-157.18%
2013-12-31	-145.42%
2013-09-30	72.94%
2013-06-30	83.29%
2013-03-31	104.96%
2012-12-31	111.73%
2012-09-30	87.25%
2012-06-30	83.78%
2012-03-31	81.58%
2011-12-31	68.58%
2011-09-30	39.47%
2011-06-30	39.28%
2011-03-31	40.76%
2010-12-31	44.58%
2010-09-30	43.52%
2010-06-30	49.77%
2010-03-31	55.64%
2009-12-31	52.54%
2009-09-30	51.97%
2009-06-30	59.85%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-24.41%
2024-12-31	-10.38%
2023-12-31	-15.33%
2022-12-31	-24.32%
2021-12-31	-26.42%
2020-12-31	-33.26%
2019-12-31	-32.15%
2018-12-31	-87.56%
2017-12-31	87.68%
2016-12-31	138.04%
2015-12-31	256.43%
2014-12-31	1141.15%
2013-12-31	-145.42%
2012-12-31	111.73%
2011-12-31	68.58%
2010-12-31	44.58%
2009-12-31	52.54%
2008-12-31	61.79%
2007-12-31	16.63%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GILEAD SCIENCES, INC. (GILD)	United States	$185.522B	-48.37
Moderna, Inc. (MRNA)	United States	$77.819B	-8.86
Revolution Medicines, Inc. (RVMD)	United States	$42.805B	-22.69
BIOGEN INC. (BIIB)	United States	$33.427B	19.60
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31